Sensex Slips as TCS Cuts Jobs; Nifty Hovers Near 24,800 Despite Global Market Lift

3 min read | July 28, 2025 05:40 PM AEST | By Team Kalkine Media

Highlights

  • Sensex and Nifty trade mixed amid volatility driven by weak banking results

  • TCS announces workforce reduction, triggering pressure in tech segment

  • Realty and private banks decline while pharma stocks edge higher

Indian equities opened on a volatile note with the benchmark Sensex and Nifty indices showing limited directional strength despite initial optimism from global peers. The day’s movement was primarily driven by domestic earnings, global trade concerns, and company-specific developments impacting sentiment across major sectors.

Broader market breadth remained tepid, reflecting hesitation among participants amid mixed signals from both domestic and international fronts.

TCS Share Weakness Follows Workforce Rationalisation Move

Tata Consultancy Services (NSE:TCS) emerged in focus after announcing a significant reduction in workforce size. The move resulted in selling pressure across information technology counters, adding to the broader weakness seen in the tech-heavy segments of the market. Market participants responded to the company’s restructuring development, contributing to its underperformance relative to peers.

The reaction in TCS further weighed on sentiment within the Nifty IT index, which had otherwise remained stable over the past few sessions.

Banking Sector Dampens Indices on Weak Earnings Print

Among the key laggards of the session, Kotak Mahindra Bank (NSE:KOTAKBANK) saw notable weakness following the release of its quarterly financial results. The subdued performance contributed to broad-based selling within the private banking segment. As a result, the Nifty Bank index traded lower, offsetting strength observed in other pockets of the market.

Investors responded to the earnings disappointment with caution, affecting both heavyweight constituents and smaller financial players.

Real Estate Stocks Under Pressure Amid Broader Sectoral Drag

The real estate sector witnessed sharp declines, led by names including Lodha (NSE:LODHA), Prestige Estates (NSE:PRESTIGE), and Oberoi Realty (NSE:OBEROIRLTY). The segment’s performance reflected a cooling off from previous sessions, amid reduced momentum and cautious outlooks among developers. The weakness in property stocks added further downward pressure to the benchmarks.

This decline comes against the backdrop of broader economic concerns and policy-related caution surrounding urban development.

Pharma Counters Provide Support With Select Stock Gains

Despite the broader weakness, the pharmaceutical space offered some resilience. Laurus Labs (NSE:LAURUSLABS) and Cipla (NSE:CIPLA) led the segment higher on the back of renewed interest in defensive sectors. Gains in pharma helped cushion losses across other cyclical sectors, offering limited support to the headline indices.

Strength in select pharma names followed positive cues in the healthcare space, often considered a safe haven in times of volatility.

Global Markets Trade Mixed as Asia and US Futures Diverge

On the international front, sentiment was uneven with the S&P/ASX 200 ASX 200 showing marginal gains, while Japan’s Topix edged lower. Hong Kong’s Hang Seng also posted a moderate uptick. US equity futures suggested a positive opening trend, though the ongoing global trade narratives remained a focus area for investors across regions.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.